Biodesix, Inc. (BDSX)
26.02
+0.39
(+1.52%)
USD |
NASDAQ |
Oct 09, 16:00
26.02
0.00 (0.00%)
After-Hours: 20:00
Biodesix Free Cash Flow : -20.47M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -20.47M |
| March 31, 2026 | -25.27M |
| December 31, 2025 | -23.70M |
| September 30, 2025 | -29.33M |
| June 30, 2025 | -31.35M |
| March 31, 2025 | -45.28M |
| December 31, 2024 | -52.13M |
| September 30, 2024 | -61.60M |
| June 30, 2024 | -60.36M |
| March 31, 2024 | -45.34M |
| Date | Value |
|---|---|
| December 31, 2023 | -45.93M |
| September 30, 2023 | -45.42M |
| June 30, 2023 | -46.84M |
| March 31, 2023 | -51.25M |
| December 31, 2022 | -48.51M |
| September 30, 2022 | -45.41M |
| June 30, 2022 | -43.10M |
| March 31, 2022 | -32.38M |
| December 31, 2021 | -30.77M |
| September 30, 2021 | -29.23M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Quest Diagnostics, Inc. | 1.349B |
| Labcorp Holdings, Inc. | 1.155B |
| OPKO Health, Inc. | -134.02M |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | -7.355M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.601M |
| Cash from Investing (Quarterly) | -0.254M |
| Cash from Financing (Quarterly) | 6.279M |
| Free Cash Flow Per Share (Quarterly) | -0.1802 |
| Free Cash Flow to Equity (Quarterly) | -2.041M |
| Free Cash Flow to Firm (Quarterly) | 0.127M |
| Free Cash Flow Yield | -8.86% |